SUTENT

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug SUTENT contains one active pharmaceutical ingredient (API):

1 Sunitinib UNII LVX8N1UT73 - SUNITINIB MALATE

Sunitinib inhibits multiple RTKs that are implicated in tumour growth, neoangiogenesis, and metastatic progression of cancer. Read about Sunitinib

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SUTENT Hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01EX01	Sunitinib	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors
Discover more medicines within L01EX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10004M, 10009T, 10010W, 10459L, 10464R, 10473F, 10503T, 10504W, 11250D, 11253G, 11256K, 11266Y, 2837H, 2842N, 2959R, 9417P, 9418Q, 9419R, 9420T, 9421W, 9422X, 9488J, 9489K, 9490L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522720050087617, 522720050087717, 522720050087817
Country: CA	Health Products and Food Branch	Identifier(s): 02280795, 02280809, 02280817
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.733-06-07, 27.734-1-03-12, 27.738-06-07
Country: EE	Ravimiamet	Identifier(s): 1257982, 1257993, 1258006, 1353282, 1353293, 1353305, 1426632, 1426643
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 06347001, 06347002, 06347003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 099863, 099872, 099881
Country: FR	Base de données publique des médicaments	Identifier(s): 63841059, 65283820, 69225978
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 136358, 136363, 136365
Country: HK	Department of Health Drug Office	Identifier(s): 55404, 55405, 55406, 59785
Country: IE	Health Products Regulatory Authority	Identifier(s): 88684, 88685, 88686
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6045, 6046, 6047
Country: IT	Agenzia del Farmaco	Identifier(s): 037192010, 037192022, 037192034
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291018M1029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1030588, 1030589, 1030590, 1030591, 1030592, 1030593, 1038372, 1038373, 1060892, 1061423
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 233M2006
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 83453, 83461, 83488
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12700, 12701, 12702, 17938
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100114829, 100116923, 100118520, 100214933
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65026001, W65027001, W65028001
Country: SG	Health Sciences Authority	Identifier(s): 13254P, 13255P, 13256P, 13920P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8013061H, 8013062H, 8013063H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308157553, 8681308158994, 8681308159427, 8681308159434, 8681308159571
Country: US	FDA, National Drug Code	Identifier(s): 0069-0550, 0069-0770, 0069-0830, 0069-0980
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/26/0195, 41/26/0196